Reverberi Gian Piero
Insider CIK 1652023 · VNDA SVP, General Manager Europe
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2020-03-02 | 2020-03-04 | 1,450 | $10.18 | $14.8K | 165,384 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2020-01-02 | 2020-01-06 | 1,155 | $16.06 | $18.5K | 166,834 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-03-04 | 2019-03-04 | 443 | $19.92 | $8.8K | 167,989 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-03-01 | 2019-03-04 | 438 | $20.17 | $8.8K | 168,432 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2019-02-27 | 2019-03-01 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2019-02-27 | 2019-03-01 | 30,000 | — | $0 | 168,870 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-01-02 | 2019-01-04 | 530 | $26.94 | $14.3K | 138,870 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | S Sale | 2019-01-02 | 2019-01-04 | 600 | $26.28 | $15.8K | 139,400 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2018-02-28 | 2018-03-02 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2018-02-28 | 2018-03-02 | 30,000 | — | $0 | 140,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 12,500 | — | $0 | 25,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2018-01-02 | 2018-01-04 | 7,500 | — | $0 | 15,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 7,500 | — | $0 | 110,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2018-01-02 | 2018-01-04 | 12,500 | — | $0 | 87,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2017-03-01 | 2017-03-03 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award | 2017-03-01 | 2017-03-03 | 30,000 | — | $0 | 50,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 7,500 | — | $0 | 22,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise deriv | 2017-01-03 | 2017-01-05 | 12,500 | — | $0 | 37,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 7,500 | — | $0 | 20,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | M Exercise | 2017-01-03 | 2017-01-05 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-02-12 | 2016-02-17 | 30,000 | — | $0 | 30,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2016-02-12 | 2016-02-17 | 70,000 | — | $0 | 70,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2015-09-08 | 2015-09-09 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VNDA Vanda Pharmaceuticals Inc. | A Award deriv | 2015-09-08 | 2015-09-09 | 150,000 | — | $0 | 150,000 | SEC↗ |